| Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results WHO Solidarity Trial Consortium New England journal of medicine 384 (6), 497-511, 2021 | 2801 | 2021 |
| Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial … AM Henao-Restrepo, A Camacho, IM Longini, CH Watson, WJ Edmunds, ... The Lancet 389 (10068), 505-518, 2017 | 1159 | 2017 |
| Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial AM Henao-Restrepo, IM Longini, M Egger, NE Dean, WJ Edmunds, ... The Lancet 386 (9996), 857-866, 2015 | 913 | 2015 |
| Animal models for COVID-19 C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell, AX Riveros-Balta, ... Nature 586 (7830), 509-515, 2020 | 876 | 2020 |
| Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group C Satzke, P Turner, A Virolainen-Julkunen, PV Adrian, M Antonio, ... Vaccine 32 (1), 165-179, 2013 | 514 | 2013 |
| SARS-CoV-2 variants and vaccines PR Krause, TR Fleming, IM Longini, R Peto, S Briand, DL Heymann, ... New England Journal of Medicine 385 (2), 179-186, 2021 | 417 | 2021 |
| Considerations in boosting COVID-19 vaccine immune responses PR Krause, TR Fleming, R Peto, IM Longini, JP Figueroa, JAC Sterne, ... The Lancet 398 (10308), 1377-1380, 2021 | 374 | 2021 |
| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 297 | 2022 |
| Data sharing for novel coronavirus (COVID-19) V Moorthy, AMH Restrepo, MP Preziosi, S Swaminathan Bulletin of the World Health Organization 98 (3), 150, 2020 | 244 | 2020 |
| Ebola vaccine—an urgent international priority R Kanapathipillai, AM Henao Restrepo, P Fast, D Wood, C Dye, MP Kieny, ... New England Journal of Medicine 371 (24), 2249-2251, 2014 | 159 | 2014 |
| COVID-19 vaccine trials should seek worthwhile efficacy P Krause, TR Fleming, I Longini, AM Henao-Restrepo, R Peto, NE Dean, ... The Lancet 396 (10253), 741-743, 2020 | 146 | 2020 |
| Measles elimination: progress and challenges FT Cutts, AM Henao-Restrepo, JM Olive Vaccine 17, S47-S52, 1999 | 141 | 1999 |
| The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola Ebola ça Suffit Ring Vaccination Trial Consortium BMJ: British Medical Journal 351, h3740, 2015 | 131 | 2015 |
| Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report PS Gsell, A Camacho, AJ Kucharski, CH Watson, A Bagayoko, ... The Lancet infectious diseases 17 (12), 1276-1284, 2017 | 106 | 2017 |
| Group A streptococcal vaccines: paving a path for accelerated development JB Dale, VA Fischetti, JR Carapetis, AC Steer, S Sow, R Kumar, ... Vaccine 31, B216-B222, 2013 | 105 | 2013 |
| A randomized, controlled trial of an aerosolized vaccine against measles N Low, A Bavdekar, L Jeyaseelan, S Hirve, K Ramanathan, NJ Andrews, ... New England Journal of Medicine 372 (16), 1519-1529, 2015 | 101 | 2015 |
| Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis N Low, S Kraemer, M Schneider, AMH Restrepo Vaccine 26 (3), 383-398, 2008 | 92 | 2008 |
| Creating a framework for conducting randomized clinical trials during disease outbreaks NE Dean, PS Gsell, R Brookmeyer, FW Crawford, CA Donnelly, ... New England Journal of Medicine 382 (14), 1366-1369, 2020 | 87 | 2020 |
| Advances and gaps in SARS-CoV-2 infection models C Muñoz-Fontela, L Widerspick, RA Albrecht, M Beer, MW Carroll, ... PLoS pathogens 18 (1), e1010161, 2022 | 81 | 2022 |
| Two-dose schedules for human papillomavirus vaccine: systematic review and meta-analysis M D'Addario, S Redmond, P Scott, D Egli-Gany, AX Riveros-Balta, ... Vaccine 35 (22), 2892-2901, 2017 | 80 | 2017 |
